Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer.
CONCLUSIONS: In AF patients with newly diagnosed cancer, NOACs showed lower incidences of ischemic stroke/SE, major bleeding, and all-cause death than warfarin, especially within 1 year after cancer diagnosis.
PMID: 29671285 [PubMed - as supplied by publisher]
Source: Korean Circulation Journal - Category: Cardiology Tags: Korean Circ J Source Type: research
More News: Atrial Fibrillation | Bleeding | Cancer | Cancer & Oncology | Coumadin | Ischemic Stroke | Oral Cancer | Stroke | Study | Vitamin K | Vitamins | Warfarin